View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AF46 | Publication ID: Fall 2008 |
Title: Substances Prohibited From Use in Animal Food or Feed To Prevent the Transmission of Bovine Spongiform Encephalopathy | |
Abstract: On October 6, 2005, the Food and Drug Administration (FDA) proposed to amend its regulations to prohibit the use of certain cattle origin materials in the food or feed of all animals to help strengthen existing safeguards to prevent the spread of bovine spongiform encephalopathy (BSE) in U.S. cattle. The discovery of a BSE-positive dairy cow in December 2003 has caused FDA to review its policies for prevention of BSE, which resulted in this rulemaking. FDA is correcting the final rule on BSE that appeared in the Federal Register of April 25, 2008 (73 FR 22719-22758). The final rule inadvertently published with incorrect dollar amounts in two separate areas: the summary of economic impacts and the paperwork burden table. | |
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 21 CFR 589.2001 | |
Legal Authority: 21 USC 321 21 USC 342 and 343 21 USC 348 21 USC 371 |
Legal Deadline:
None |
||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
RIN Data Printed in the FR: Yes | |
Agency Contact: Burt Pritchett Biologist Department of Health and Human Services Food and Drug Administration Center for Veterinary Medicine, Room 2654 (MPN-4, HFV-222), 7519 Standish Place, Rockville, MD 20855 Phone:240 453-6860 Fax:240 453-6882 Email: burt.pritchett@fda.hhs.gov |